Your session is about to expire
← Back to Search
Time-Restricted Eating for Prediabetes
N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months (pre-post intervention)
Awards & highlights
Study Summary
This trial will study the effects of time-restricted eating, or TRE, on key metabolic outcomes in people with obesity and prediabetes. TRE involves restricting food intake to 6-12 hours per day, with no energy intake the rest of the day. The trial will last 12 weeks, and will help researchers understand the implications of TRE on cardiometabolic health.
Who is the study for?
This trial is for adults with obesity (BMI of 30-39.9) and prediabetes, who usually eat over a 15-hour period daily, and have stable weight without major chronic diseases or recent cancer. It's not for shift workers, frequent travelers across time zones, those doing structured exercise over 150 minutes weekly, with sleep disorders or unstable diets.Check my eligibility
What is being tested?
The study tests if eating within a 9-hour window can improve heart health and blood sugar control in people with obesity and prediabetes. Participants will follow this diet for 12 weeks to see changes in insulin sensitivity and body rhythms without losing weight.See study design
What are the potential side effects?
While the trial doesn't involve medication that could cause side effects, changing eating patterns may lead to hunger outside of the eating window, potential digestive discomfort as the body adjusts to new meal times, or changes in energy levels.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months (pre-post intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months (pre-post intervention)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
24 h glycemic control
Adipose tissue gene expression
Insulin sensitivity
Secondary outcome measures
Peripheral diurnal rhythmicity in in peripheral mononuclear blood cells
Trial Design
2Treatment groups
Experimental Treatment
Group I: TRE groupExperimental Treatment1 Intervention
Time-restricted eating group
Group II: Control groupExperimental Treatment1 Intervention
Time-unrestricted eating group
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
911 Previous Clinical Trials
4,709,483 Total Patients Enrolled
29 Trials studying Obesity
33,469 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have gone through menopause.Your blood sugar levels are moderately high when fasting or after a glucose test.I was diagnosed with cancer within the last 5 years.I am under the age of 18.I have a sleep disorder.You use tobacco or illegal drugs.You should not eat any food after 6:00 pm once a week.You typically eat for more than 15 hours each day.I am not on medications that could interfere with the study.You work night shifts or have recently traveled across different time zones.I have type 2 diabetes or another major chronic illness.You have had a lot of exposure to radiation from medical procedures in the past year.You regularly fast for more than 12 hours a day, or you follow a vegan diet.You usually wake up before 4:00 AM and go to bed before 10:30 PM.I have had surgery on my digestive system or for weight loss.Your body mass index is between 30 and 39.9, which means you are considered obese.You need to exercise for at least 150 minutes every week.Your weight has changed by more than 5% in the last 2 months.I am able to understand and follow the study's requirements.
Research Study Groups:
This trial has the following groups:- Group 1: TRE group
- Group 2: Control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who is able to partake in this trial's enrollment process?
"This medical study is seeking 100 participants aged 21-70 with self-reported prolonged eating habits and a body mass index between 30 and 39.9, who have been diagnosed as obese."
Answered by AI
Are octogenarians being considered as participants in this investigation?
"The requisite age range for this medical trial is 21 - 70 years old, as per the eligibility criteria."
Answered by AI
How many individuals are actively participating in this experimentation?
"Yes, the information available on clinicaltrials.gov attests that recruitment is still ongoing for this medical trial which was first posted on November 20th 2020 and last edited on June 3rd 2022. A total of 100 patients are required at a single site."
Answered by AI
Are there currently any participants being sought for this research project?
"Correct. According to clinicaltrials.gov, the trial posted on November 20th 2020 is actively recruiting individuals for participation. The latest update was added on June 3rd 2022 and 100 people are required at 1 medical centre."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger